NOV 20, 2015 4:57 PM PST

Alcoholism Drug Brings Out Dormant HIV-Infected Cells - So That It Can Be Destroyed

WRITTEN BY: Julianne Chiaet

A new use of an old drug might be the "game changer” researchers were looking for in their quest to cure HIV.

Disulfiram, a drug used to treat alcoholism, drags latent HIV out of hiding, without any harmful side-effects. Once dragged out, the virus can be targeted and destroyed. The discovery is an important step towards tackling HIV latency. HIV latency allows the virus to integrate into the DNA of the host cell and avoid the immune system. While the latent virus doesn't usually cause symptoms, doctors still need to destroy it. Unfortunately, it is nearly impossible to target and remove the latent virus from the cell without destroying the cell itself.
 
 
Researchers have come one step closer to eradicating HIV.


Scientists have found drugs in the past that draw the virus out. Those drugs, however, induce too many toxic side-effects to be considered an option for treatment. 

Infectious disease scientist Sharon Lewin led a team of international researchers in a quest to find a non-toxic drug capable of activating HIV in the body. The findings were published in The Lancet on November 16, 2015. 

Researchers in Melbourne and San Francisco gave Disulfiram to 30 HIV positive participants in progressively higher doses for three days. The first two dosages, 500mg and 1000mg, did not produce a measured effect. The third dose, 2000 mg, drew the dormant virus out. On day 10, the amount of virus RNA in the participant's blood plasma increased by 70 percent. On day 30, the amount increased to 100 percent.

Unlike the other drugs, no serious side effects were recorded.

Researchers now need to figure out how the drug reacts in combination with other HIV therapies, and how will it affect patients who take the drug over a longer period of time. 

While there are still unanswered questions, Disulfiram has the potential to help the 35 million people living with HIV today. 


Sources: The Lancet, The University of Melbourne via The Melbourne NewsroomWHO, ScienceAlert
 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
APR 23, 2020
Clinical & Molecular DX
APR 23, 2020
FDA Approves At-Home Sample Collection Diagnostic Test for COVID-19
The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). M ...
MAY 01, 2020
Microbiology
MAY 01, 2020
Once Thought to Make COVID-19 Worse, ACE Inhibitors Now Tested as Therapeutic
Researchers were once concerned that blood pressure medications may increase the risk of infection, or make an infection ...
MAY 07, 2020
Clinical & Molecular DX
MAY 07, 2020
An 8 Minute DNA Test For Salmonella
Australian researchers have created a sensitive, super-fast test for five different serotypes of Salmonella which could ...
MAY 12, 2020
Chemistry & Physics
MAY 12, 2020
Improvised Face Covering: Finding Alternatives to Standard Masks During a Pandemic
On April 3rd, the US Centers for Disease Control and Prevention announced that they recommend members of the general pub ...
MAY 09, 2020
Chemistry & Physics
MAY 09, 2020
Blood test monitors fat intake
Research published in the Journal of Lipid Research highlights a new blood test that is able to monitor an individual&rs ...
MAY 23, 2020
Cancer
MAY 23, 2020
A New Biomarker to Identify a Triple Negative Breast Cancer Prognosis
Breast cancer, one of the most common cancers in the world, are commonly separated into one of several sub-types. These ...
Loading Comments...